Microbix Biosystems Company Executives

MBX Stock  CAD 0.24  0.01  4.00%   
Microbix Biosystems employs about 15 people. The company is managed by 15 executives with a total tenure of roughly 139 years, averaging almost 9.0 years of service per executive, having 1.0 employees per reported executive. Analysis of Microbix Biosystems' management performance can provide insight into the firm performance.
Cameron Groome  CEO
President, Chief Executive Officer, Director
Vaughn EmbroPantalony  CEO
President CEO, Director
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Microbix Biosystems Management Team Effectiveness

The company has return on total asset (ROA) of (0.0261) % which means that it has lost $0.0261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0801) %, meaning that it generated substantial loss on money invested by shareholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 16th of January 2026, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.04. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.
As of the 16th of January 2026, Common Stock Shares Outstanding is likely to grow to about 168 M, though Net Loss is likely to grow to (2.5 M).
Microbix Biosystems maintains a total of 138.81 Million outstanding shares. Microbix Biosystems secures 14.48 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
1996-12-31
Previous Quarter
140.6 M
Current Value
139.3 M
Avarage Shares Outstanding
69.4 M
Quarterly Volatility
38.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Microbix Biosystems in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Microbix Biosystems, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Microbix Biosystems Workforce Comparison

Microbix Biosystems is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 493. Microbix Biosystems adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Microbix Biosystems Profit Margins

The company has Profit Margin (PM) of (0.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.38.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.630.61
Sufficiently Up
Very volatile

Microbix Biosystems Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Microbix Biosystems Price Series Summation is a cross summation of Microbix Biosystems price series and its benchmark/peer.

Microbix Biosystems Notable Stakeholders

A Microbix Biosystems stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Microbix Biosystems often face trade-offs trying to please all of them. Microbix Biosystems' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Microbix Biosystems' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Cameron GroomePresident, Chief Executive Officer, DirectorProfile
Vaughn EmbroPantalonyPresident CEO, DirectorProfile
William GastleFounder, Executive Chairman, Member of Audit Committee and Member of HR, Compensation and Governance CommitteeProfile
Martin MarinoIndependent Chairman of the BoardProfile
Philip CasselliSenior Vice President - Business Development and Sales, MarketingProfile
Kathryn FrohVice President - DiagnosticsProfile
James CurrieChief Financial OfficerProfile
Kenneth HughesChief Operating OfficerProfile
Mark CochranIndependent DirectorProfile
Joseph RennerLead, Independent DirectorProfile
Peter BlecherIndependent DirectorProfile
Kevin CassidySenior Vice President Sales and Business DevelopmentProfile
Mark LuscherSenior Vice President - Scientific AffairsProfile
Christopher LobbGeneral OfficerProfile
Phillip CasselliSenior DevelopmentProfile
String symbol = request.getParameter("s");

About Microbix Biosystems Management Performance

The success or failure of an entity such as Microbix Biosystems often depends on how effective the management is. Microbix Biosystems management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Microbix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Microbix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.04)(0.04)
Return On Assets(0.05)(0.06)
Return On Equity(0.07)(0.08)

Microbix Biosystems Workforce Analysis

Traditionally, organizations such as Microbix Biosystems use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Microbix Biosystems within its industry.

Microbix Biosystems Manpower Efficiency

Return on Microbix Biosystems Manpower

Revenue Per Employee1.2M
Revenue Per Executive1.2M
Net Loss Per Employee149.7K
Net Loss Per Executive149.7K
Working Capital Per Employee1.4M
Working Capital Per Executive1.4M

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.